Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels. (Q48256184)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels. |
scientific article |
Statements
1 reference
Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels. (English)
1 reference
K Hänel
K Czaja
4 November 2014
1 reference